Avita Medical

267 articles about Avita Medical

• Avita Medical Presents More Positive ReCell Repigmentation Trial Results

  6/11/2014

• Avita Medical Appoints New Chairman

  5/20/2014

• FDA Release: Avita Medical Grants An Investigational Device Exemption For Compassionate Use Of ReCell

  4/10/2014

• Avita Medical Release: ReCell Containing Ambient-Stored Enzyme Launched In United Kingdom And Europe

  4/9/2014

• Avita Medical CEO Steps Down After First Strike, Interim Chief Named

  12/12/2013

• Avita Medical Announces Completion of Enrollment in ReCell® Trial for Vitiligo

  8/21/2013

• Avita Medical Enrolls First Patients in ReCell® Trial for Chronic Leg Ulcers

  8/1/2013

• Avita Medical Release: Granted Japanese Patent Expands Commercial Rights for ReCell® Spray-On Skin® Technology in Asia

  4/10/2013

• Avita Medical Skin Regeneration Symposium Attracts Top European Surgeons

  3/28/2013

• Avita Medical Completes ISO Quality Audit, CE Mark Recertification

  2/14/2013

• Avita Medical CEO William Dolphin, Ph.D. Interviewed by Stock News Now

  2/14/2013

• Avita Medical Appoints Dr. Michael S. Perry to Board of Directors

  2/7/2013

• Avita Medical Initiates European Trial Using ReCell in the Management of Chronic Lower Limb Ulcers

  11/20/2012

• Avita Medical to Present at SoCalBio Investor Conference & Exhibition

  11/5/2012

• Avita Medical Strengthens Board

  10/23/2012

• Avita Medical Release: $10.2 Million Capital Raising Oversubscribed

  10/23/2012

• Avita Medical Secures Additional Funding From U.S. Department of Defense

  10/1/2012

• Avita Medical Announces ReCell Presentations at the 16th Congress of the International Society for Burn Injuries (ISBI)

  9/12/2012

• Cornerstone Institutional Investors Head Avita Medical 's $10 Million Capital Raising

  9/10/2012

• Avita Medical Announces Manufacturing Advances

  8/28/2012